60 Degrees Pharmaceuticals (SXTP) Other Non-Current Assets (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Other Non-Current Assets of $243212.0 for Q1 2026, up 1002.55% year-over-year from $22059.0 in Q1 2025, and up 8.4% quarter-over-quarter from $224361.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Other Non-Current Assets (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Other Non-Current Assets for 5 consecutive years, with $243212.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 1002.55% year-over-year to $243212.0; the TTM figure through Mar 2026 stood at $243212.0 (up 1002.55% YoY), while the FY2025 annual figure was $224361.0, up 239.04% from the prior year.
- Other Non-Current Assets grew to $243212.0 in Q1 2026 per SXTP's latest filing, from $224361.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.4 million in Q2 2023 and bottomed at $22059.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $352408.5 across 5 years, with a median of $243212.0 in 2026.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets plunged 88.89% — and 2026, when it surged 1002.55%.
- 60 Degrees Pharmaceuticals' Other Non-Current Assets stood at $176902.0 in 2022, then surged by 173.27% to $483422.0 in 2023, then tumbled by 86.31% to $66176.0 in 2024, then soared by 239.04% to $224361.0 in 2025, then climbed by 8.4% to $243212.0 in 2026.
- Business Quant data shows SXTP's Other Non-Current Assets at $243212.0 in Q1 2026, $224361.0 in Q4 2025, and $22059.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 308,683.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,212.00 |
| Dec 31, 2025 | 224,361.00 |
| Mar 31, 2025 | 22,059.00 |
| Dec 31, 2024 | 66,176.00 |
| Sep 30, 2024 | 374,645.00 |
| Jun 30, 2024 | 404,515.00 |
| Mar 31, 2024 | 198,529.00 |
| Dec 31, 2023 | 483,422.00 |
| Sep 30, 2023 | 251,581.00 |
| Jun 30, 2023 | 1.43 Mn |
| Dec 31, 2022 | 176,902.00 |